Andrew Bird

Southwestern University — United States

Medicine · Health Sciences

23h-index2.1kcitations49works5.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lysosomal Storage Disorders Research(15), Virus-based gene therapy research(11), Glycogen Storage Diseases and Myoclonus(11), Neurogenetic and Muscular Disorders Research(10), Genetics and Neurodevelopmental Disorders(9)

Publications49 total

Towards a common approach for managing food allergy and serious allergic reactions (anaphylaxis) at school. GA<sup>2</sup>LEN and EFA consensus statement
Clinical and Translational Allergy·2024· 7 citedOpen Access
10 practical priorities to prevent and manage serious allergic reactions: GA<sup>2</sup>LEN ANACare and EFA Anaphylaxis Manifesto
Clinical and Translational Allergy·2024· 4 citedOpen Access
Pooled Safety Data from Phase 3 Studies of Epicutaneous Immunotherapy for Peanut Allergy in Children Aged 4-11 Years
Journal of Allergy and Clinical Immunology·2022
866 CD252 (OX40L)+ ANTIGEN PRESENTING CELLS ARE PRESENT IN THE ACTIVE EOE ESOPHAGEAL EPITHELIUM
Gastroenterology·2020
311. In Vivo Zinc Finger Nuclease-Mediated Targeted Integration of a Glucose-6-Phosphatase Transgene Enhances Biochemical Correction in Mice with Glycogen Storage Disease Type IA
Molecular Therapy·2016Open Access
In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA
Molecular Therapy·2016· 28 citedOpen Access
Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β <sub>2</sub> -Agonist in Murine Pompe Disease
Human Gene Therapy·2015· 16 citedOpen Access
510. Synergistic Efficacy from Gene Therapy with Pompe Disease Using Anti-CD4 mAb and a Beta-Agonist, Clenbuterol
Molecular Therapy·2015Open Access
Adjunctive β <sub>2</sub> ‐agonist treatment reduces glycogen independently of receptor‐mediated acid α‐glucosidase uptake in the limb muscles of mice with Pompe disease
The FASEB Journal·2014· 14 citedOpen Access
Adjunctive 2-agonist therapy enhanced biochemical correction and biomarker reduction from an AAV vector expressing acid alpha-glucosidase in the skeletal muscle of mice with Pompe disease
Molecular Genetics and Metabolism·2013
Enhanced gene expression of systemically administered plasmid DNA in the liver with therapeutic ultrasound and microbubbles
IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control·2013· 7 cited
Adjunctive β2‐agonists reverse neuromuscular involvement in murine Pompe disease
The FASEB Journal·2012· 40 citedOpen Access
Enhanced gene expression of systemically administered plasmid DNA inthe liver with therapeutic ultrasound and microbubbles
Data Archiving and Networked Services (DANS)·2012Open Access
Deficiency in MyD88 Signaling Results in Decreased Antibody Responses to an Adeno-Associated Virus Vector in Murine Pompe Disease
BioResearch open access·2012· 9 citedOpen Access
Long-Term Efficacy Following Readministration of an Adeno-Associated Virus Vector in Dogs with Glycogen Storage Disease Type Ia
Human Gene Therapy·2011· 33 citedOpen Access
Hepatorenal Correction in Murine Glycogen Storage Disease Type I With a Double-stranded Adeno-associated Virus Vector
Molecular Therapy·2011· 36 citedOpen Access
Antibody formation and mannose‐6‐phosphate receptor expression impact the efficacy of muscle‐specific transgene expression in murine Pompe disease
The Journal of Gene Medicine·2010· 27 citedOpen Access
Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease
Gene Therapy·2010· 12 citedOpen Access
Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease
Molecular Therapy·2009· 80 citedOpen Access
Impaired clearance of accumulated lysosomal glycogen in advanced Pompe disease despite high‐level vector‐mediated transgene expression
The Journal of Gene Medicine·2009· 26 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Dwight D. Koeberl(32), Baodong Sun(23), Songtao Li(14), T. T. Brown(10), Sarah P. Young(10), Haoyue Zhang(7), Priya S. Kishnani(6), Ayn Schneider(5), Andrea Amalfitano(4), Y.T. Chen(4), Daniel K. Benjamin(4), Mark W. Jackson(4), Xiaoyan Luo(4), Luis M. Franco(3), Y.-T. Chen(3), Steven L Hillman(3), D.D. Koeberl(3), R M Beaty(3), Alex R. Kemper(3), Dustin J. Landau(3)